COVID-19幸存者肺部免疫代谢活性增高
研究前瞻性纳入53例既往中重度COVID-19肺炎住院幸存者,与45名对照者比较,采用18F-FDG PET/CT定量全肺及高、低衰减区摄取值并检测血浆炎症、凝血及内皮活化标志物。结果显示幸存者肺部正常及致密区域代谢活性增高,血浆促炎、凝血及内皮活化标志物浓度显著升高。
要点
- 中重度COVID-19肺炎幸存者症状出现数月后肺部正常及致密区域代谢活性仍增高。
- 幸存者血浆促炎、凝血及内皮活化标志物浓度显著高于对照者。
- 所有幸存者报告至少1种持续症状,41.5%报告超过6种症状。
核心结论
- 中重度COVID-19肺炎后数月,幸存者肺部高衰减及正常衰减区域代谢活性增高,血浆血栓炎症及内皮活化标志物持续存在。
研究设计与样本
- 前瞻性纳入既往因中重度COVID-19肺炎住院的成人幸存者,45名志愿者作为对照者,两组均行胸部CT和18F-FDG PET/CT并行基于体素的定量分析。
主要发现
- 共纳入53例COVID-19幸存者,62.3%为男性,中位年龄50岁。
- 所有幸存者报告至少1种持续症状,41.5%报告超过6种症状。
- 幸存者平均肺密度高于对照者,且症状出现数月后正常及致密肺区域代谢活性高于对照者。
- 幸存者血浆促炎、凝血及内皮活化标志物浓度显著高于对照者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We quantified lung glycolytic metabolic activity, clinical symptoms and inflammation, coagulation, and endothelial activation biomarkers in 2019 coronavirus disease (COVID-19) pneumonia survivors. METHODS: Adults previously hospitalized with moderate to severe COVID-19 pneumonia were prospectively included. Subjects filled out a questionnaire on clinical consequences, underwent chest CT and 18 F-FDG PET/CT, and provided blood samples on the same day. Forty-five volunteers served as control subjects. Analysis of CT images and quantitative voxel-based analysis of PET/CT images were performed for both groups. 18 F-FDG uptake in the whole-lung volume and in high- and low-attenuation areas was calculated and normalized to liver values. Quantification of plasma markers of inflammation (interleukin 6), d -dimer, and endothelial cell activation (angiopoietins 1 and 2, vascular cell adhesion molecule 1, and intercellular adhesion molecule 1) was also performed. RESULTS: We enrolled 53 COVID-19 survivors (62.3% were male; median age, 50 years). All survivors reported at least 1 persistent symptom, and 41.5% reported more than 6 symptoms. The mean lung density was greater in survivors than in control subjects, and more metabolic activity was observed in normal and dense lung areas, even months after symptom onset. Plasma proinflammatory, coagulation, and endothelial activation biomarker concentrations were also significantly higher in survivors. CONCLUSION: We observed more metabolic activity in areas of high and normal lung attenuation several months after moderate to severe COVID-19 pneumonia. In addition, plasma markers of thromboinflammation and endothelial activation persisted. These findings may have implications for our understanding of the in vivo pathogenesis and long-lasting effects of COVID-19 pneumonia.
引用
- Rodrigues RS, Motta Ribeiro G, Barreto MM, et al. Increased Lung Immune Metabolic Activity in COVID-19 Survivors. Clin Nucl Med. 2022. PMID: 36026599. doi:10.1097/RLU.0000000000004376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。